Stay updated on Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedNew revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0'. This update does not change study details, eligibility criteria, or results displayed on the page.SummaryDifference0.0%

- Check9 days agoChange DetectedShow glossary feature added to the page and metadata now includes Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous capitalization variants and the older Revision: v3.3.4 were replaced.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4, with the page displaying Revision: v3.3.4.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded a Locations section including Ontario. Removed Ontario Locations and the HHS Vulnerability Disclosure (revision 3.3.2 to 3.3.3).SummaryDifference0.1%

- Check74 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.2, replacing the previous PubMed-origin wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page removed an administrative notice about government funding and NIH operations, which does not affect the study details, results, or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.